Insights On Upstream Manufacturing

  1. A Platform That's Revolutionizing Biopharma Manufacturing 5/26/2026

    Integrated platform boosts biologics manufacturing by raising protein yield, speeding timelines, and improving scalability via cell line development, process optimization, and data-driven design.

  2. Get Up To 4X Titer With N-1 Perfusion 5/26/2026

    N-1 perfusion improves antibody production by increasing cell density, optimizing media and conditions, boosting yields up to 4.5× while maintaining quality and reducing manufacturing time and costs.

  3. Advancing Therapeutic Discovery With High-Throughput Electroporation 5/21/2026

    Learn how high-throughput electroporation streamlines genetic material delivery for cell therapy and drug discovery, offering speed, precision, and scalability across hard-to-transfect cell types.

  4. Turning Gene Therapies Into Patient Reality: Large Scale Cost-Effective AAV Production 5/19/2026

    Understanding how upstream control, downstream efficiency, and process robustness scale together is essential for protecting supply and expanding patient access.

  5. The Science Fueling Cell Culture Optimization For Biologic Therapies 5/18/2026

    Boost mAb titers by over 60% with an optimized intensified fed-batch process, no new equipment required. See the data.

  6. In Vivo Manufacturing: When The Body Becomes The Bioreactor 5/15/2026

    Breakthrough therapies are reshaping medicine, but manufacturing complexity is holding them back. Discover how rethinking production and delivery could expand reach and improve patient experience.

  7. The Body As A Bioreactor – The Vision 5/15/2026

    As cell therapy manufacturing reaches its limits, a new model is emerging. Learn how in vivo approaches that harness the body as a bioreactor could expand access and reshape the future.

  8. Enabling A Four-Fold Increase In Titer For mAb Manufacturing 5/14/2026

    A platform-based upstream strategy increased monoclonal antibody titers fourfold, improving yield, efficiency, and scalability via optimized clones, process design, and rapid scale-up.

  9. Unlock The Potential Of GPEx® Lightning: Accelerate Your HEK Cell Line Development 5/8/2026

    Cut HEK cell line development to four months with 30% higher titers. GPEx® Lightning delivers faster, scalable biologics manufacturing. Access the full summary now.

  10. Comprehensive Bioprocess Control: Substrate, Metabolite And Product Analysis 5/6/2026

    Explore how multi-parameter bioprocess analyzers support monitoring of 30+ bioprocess parameters across mammalian and microbial systems to optimize yield and product quality.